News

EQT Life Sciences Secures €54M for ATB Therapeutics Growth

EQT Life Sciences Secures €54M for ATB Therapeutics Growth

EQT Life Sciences Secures Major Investment for Clinical Advancement

EQT Life Sciences has made headlines with its recent investment in ATB Therapeutics, providing a substantial €54 million through a Series A financing round. This financial support aims to catalyze the clinical development of groundbreaking oncology and immunology therapeutics derived from ATB's innovative antibody payload platform.

Funding Purpose and Innovative Technologies

The funds raised will primarily support the clinical advancement of ATB Therapeutics' unique drug pipeline, which leverages advanced technologies to create effective biological therapies. ATB's proprietary ATBioFarm platform allows for rapid and scalable production of cutting-edge therapeutic antibodies that incorporate novel mechanisms for targeting and killing cancer cells. These improvements bolster both the safety and efficacy of the treatments.

Leading the Charge: Key Appointments

In a strategic move, Mark Throsby, a well-respected executive in the biotech realm and the former Chief Scientific Officer of Merus, will assume the role of Executive Chairman at ATB Therapeutics. Throsby brings a wealth of experience in antibody therapeutics, which will enhance ATB's leadership as the company embarks on this pivotal growth phase. Joining him on the Board of Directors are seasoned investors John de Koning and Karin Kleinhans, further strengthening the company's governance and strategic direction.

Expanding Operations and Future Outlook

With the infusion of capital, ATB Therapeutics plans to not only enhance its existing facilities but also establish a state-of-the-art pilot manufacturing plant in Marche-en-Famenne, complemented by expanded research operations in Ghent. This move is indicative of ATB's commitment to driving innovation and meeting the growing needs in the treatment landscape for complex diseases.

CEO's Vision for Transformative Therapies

Bertrand Magy, CEO and co-founder of ATB Therapeutics, expressed his confidence in the company's vision, noting that the successful fundraising reflects the immense potential of the ATBioFarm platform. This funding will allow ATB to significantly bolster its R&D team and capabilities, steering the company toward delivering transformative therapies to patients globally.

Innovating Antibody Platforms

The ATBioFarm platform is recognized for its ability to swiftly and effectively generate a diverse range of candidate molecules, exhibiting unique cytotoxic and targeting features. This innovative strategy addresses significant hurdles in selecting effective antibody-drug conjugate candidates and offers new mechanisms of action that align with unmet clinical needs.

Industry experts have remarked on the novel approach ATB Therapeutics has taken in establishing a proprietary platform that integrates drug discovery, development, and manufacturing. This vertical integration is unique, providing ATB with a competitive advantage as it positions itself as a leader in the next generation of biopharmaceuticals.

Contact Information

For further inquiries, please reach out to the EQT Press Office for more insight into this strategic partnership and investment in ATB Therapeutics. The commitment to developing innovative treatments that meet critical health needs in oncology and immunology remains steadfast in the initiatives driven by this funding.

Frequently Asked Questions

What is the significance of the €54 million investment?

This investment is aimed at accelerating the clinical development of innovative therapeutics in oncology and immunology derived from ATB Therapeutics' advanced antibody platform.

Who will lead ATB Therapeutics following the investment?

Mark Throsby has been appointed as Executive Chairman, bringing valuable experience in antibody development to the company.

What is the ATBioFarm platform about?

The ATBioFarm platform allows for the scalable, efficient production of antibodies that integrate multiple targeting and killing mechanisms, enhancing therapeutic effectiveness.

Where will the new operations be based?

ATB Therapeutics plans to expand its operations in Ghent while setting up a cutting-edge pilot manufacturing facility in Marche-en-Famenne.

How does this funding impact ATB’s trajectory?

The funding significantly enhances ATB's capacity to innovate and develop transformative therapies, positioning the company as a frontrunner in biopharmaceutical advancements.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

EQT Expands Satellite Infrastructure with Key Acquisition

Updated Category News Views 39

Satellite Bold Move by EQT I'll tell ya, acquisitions like this feel like a chess grandmaster playing an opening move—bold, calculated, and bound to shake up the board. We've got EQT-backed SatPort Infrastructure snapping up a teleport business from Speedcast. Now, this ain't just another small-time bout; we're talking about beefing up SatPort's satellite ground...

Continue Reading
Cepheid's FDA Clearance Boosts Hemorrhagic Fever Test

Updated Category News Views 111

Quick Detection for Deadly Viruses In the world of diagnostics, speed isn't just a luxury; it's a lifeline. Cepheid’s latest move—getting the FDA’s nod for their Xpert Hemorrhagic Fever Panel Test—is a big deal. Why? Imagine being able to detect nasty viruses like Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever in just over an hour. That's what this...

Continue Reading
UN Forum Unleashes LatAm CEO Coalition for Action

Updated Category News Views 73

Latin America Takes Center Stage When the UN turns its spotlight on a region, you know there's something afoot. Right in Montevideo, Uruguay, the United Nations Global Compact gathered a hefty crowd of over 300 leaders from diverse backgrounds—think business, finance, government, and academia. What they were brewing wasn’t just talk; it was about driving real change...

Continue Reading
Telemed Sites Need Solid Payment Systems with AI

Updated Category News Views 115

Brace for Impact: Payment Processors in Telehealth A new era is brewing in telehealth, with AI coding tools making website creation a breeze for healthcare folks. But here's the kicker: accepting credit cards is not as easy as setting up a snazzy booking page. Take it from Organic Payment Gateways in good ol' Scarborough, Maine, who've decided to toss their hat into this...

Continue Reading
Ian Marx Wins Pro Bono Honor at NJ Legal Awards

Updated Category News Views 58

A Champion in Legal Advocacy How often do we hear about a lawyer choosing the unglamorous path of pro bono work over the high-stakes allure of corporate law? Slam-dunk, you don’t. At the New Jersey Legal Awards, Ian S. Marx from Greenberg Traurig broke the mold, snagging the 'Pro Bono Lawyer of the Year' award. This isn’t just some pat on the back; it's recognition of...

Continue Reading
Levvy AI: Transforming Hidden Hours into Advisory Gold

Updated Category News Views 16

Unlocking Hidden Potential: Levvy AI on the Scene Picture this: you're running an accounting shop and drowning in an ocean of endless tasks, manual entries, and those cursed follow-ups. That's probably the daily grind, right? Well, it looks like Levvy has decided to break those shackles. This company, based over there in Brooklyn, is rolling out these fancy Levvy AI...

Continue Reading
Sesame Software's Game-Changer: Smooth CRM Switch

Updated Category News Views 143

Why Leaving Salesforce Isn't as Crazy as It Sounds Stepping away from Salesforce isn't your run-of-the-mill decision for businesses. It’s more like abandoning ship, anticipating lurking dangers: losing cherished data, facing burdensome API restrictions, and fretting over years of trapped history. It’s not as simple as flipping a switch, and that’s what keeps most...

Continue Reading
Atkins Takes Helm at IEA's Coal Advisory Board

Updated Category News Views 45

Leadership Shake-up in the Energy World Who would've thought? Randall W. Atkins, Ramaco Resources' top gun, has just bagged a primo gig as the top dog at the International Energy Agency's Coal Industry Advisory Board (CIAB). Named by unanimous vote, he's about to steer this ship through the ever-evolving waters of coal's future. Now, I know some folks roll their eyes at...

Continue Reading
Meteor Education Bolsters CTE Reach with AET Labs Buy

Updated Category News Views 85

Meteor's Move: AET Labs Picked Up in CTE Plays You see, Meteor Education ain't sitting on its hands, that's for sure. They're out here hoarding strategic pieces like it's a chess match, snatching up AET Labs to bolster their already sturdy CTE playbook. No financial details spilled, but hell, that’s par for the course. This move plants them even more firmly in New...

Continue Reading
Autoliv Snaps Up MCF Safety Belts to Boost Growth

Updated Category News Views 140

Strategic Moves in Vehicle Safety Listen up! Autoliv is playing its cards right by snatching up Italy's MCF Safety Belts. Even for us with skin in the automotive game, it's clear why this matters. We're not talking just any acquisition, but one that steers Autoliv beyond conventional passenger cars. By grabbing MCF's niche expertise, Autoliv is showing it's ready to...

Continue Reading

Top 5 Most Recently Viewed Articles

PLAY Airlines' Flight Capacity Adjustment for Growth in Revenue

Updated Category News Views 201

Unit Revenue Growth Amid Capacity Adjustments In a recent update, PLAY Airlines reported that it transported a total of 86,893 passengers in February. This figure shows a marked decrease from 106,042 passengers the previous February, marking a 13.8% reduction in capacity. The adjustment comes as the airline opted to lease one of its planes to GlobalX in Miami and refine...

Continue Reading
Tecan's Q3 2025 Update Shows Positive Growth Trends

Updated Category News Views 228

Positive Performance in Third Quarter 2025 The Tecan Group today offered insights into its performance for the third quarter of 2025, showcasing notable achievements amidst evolving market conditions. As a leader in laboratory automation, Tecan has managed to record a mid-single-digit growth in sales during this quarter, signaling a positive shift from previous declines...

Continue Reading
Four Loko Launches Exciting Camo Flavor for 2025 Season

Updated Category News Views 3938

Four Loko's New Camo Flavor Unleashed for 2025 Four Loko, renowned for its adventurous and vibrant flavored malt beverages, is thrilled to announce the arrival of its latest flavor, Camo, for the upcoming 2025 Loko Season. This new offering embraces the brand's fearless and vibrant spirit, promising to take celebrations to an entirely new level. Continuing a Legacy of...

Continue Reading
PIMCO Anticipates Steady UK Budget Amid Positive Debt Outlook

Updated Category News Views 220

PIMCO Insights on the Upcoming UK Budget Senior executives from global asset manager PIMCO recently shared their thoughts regarding the UK's financial landscape, suggesting that the next budget is unlikely to shock investors. With the government preparing for its initial tax and spending plans, the sentiment around gilts, or UK government bonds, seems to be more favorable...

Continue Reading
Fidelity National Financial Boosts Quarterly Dividend by 4%

Updated Category News Views 53

Fidelity National Financial Increases Quarterly Cash Dividend Fidelity National Financial, Inc. (NYSE: FNF) is proud to announce a 4% increase in its quarterly cash dividend, now set at $0.50 per common share. This increase, up from $0.48 per share, reflects the company’s commitment to delivering value to its shareholders amid a robust financial performance. The...

Continue Reading